Follow the Pharming Group N.V. stock price and the full insider trade history of the company, a publicly traded company based in Netherlands. Shares are listed on the NL market, under the authority of AFM. Operating in the Healthcare & Pharma sector, Pharming Group N.V. has recorded 122 insider filings. Market capitalisation: €815.4m. The latest transaction was reported on 28 May 2026 (Purchase). Among the most active insiders: S. de Vries. Every trade is openly available.
122
Insider Decl.
n/a
Thresholds
€88m
111 ops.
Buy Volume
€398,700
4 ops.
Sell Volume
Buys €88m€398,700 Sells
Fundamental score
Ranked 17,640 of 29,055 companies
45.5
score / 100
Value
43
Quality
49
FCF yld7.7%
Earn yld0.4%
EV/EBITDA23.6x
ROE3.6%
Gross mgn88%
Net mgn0.8%
Debt/EBITDA3.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Pharming Group N.V. is a biopharmaceutical company focused on developing treatments for rare diseases. It is listed on the Amsterdam Stock Exchange (XAMS).